Roche is helping labs improve patient care with high medical value assays that provide critical, actionable insights to inform therapeutic decisions for treating cancer. Our high medical value assays and companion diagnostics solutions are ready to use and are fully automated to streamline workflow and ensure patient safety.
Roche offers the largest menu of ready-to-use IHC assays across disease states, including predictive assays with the greatest number of therapies on label. Our leading portfolio of companion diagnostics represents access to a broad range of cancer therapies.
Ready-to-use reagents
Pre-diluted for consistent and reproducible results
Individual protocol tunability
To achieve optimal staining intensity for each marker
Fully automated
Optimized for use on BenchMark systems